PH24299A - Controlled release drug-containing fibers - Google Patents

Controlled release drug-containing fibers

Info

Publication number
PH24299A
PH24299A PH35541A PH35541A PH24299A PH 24299 A PH24299 A PH 24299A PH 35541 A PH35541 A PH 35541A PH 35541 A PH35541 A PH 35541A PH 24299 A PH24299 A PH 24299A
Authority
PH
Philippines
Prior art keywords
controlled release
release drug
containing fibers
fibers
drug
Prior art date
Application number
PH35541A
Other languages
English (en)
Inventor
William John Curatolo
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of PH24299A publication Critical patent/PH24299A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
    • A61J3/07—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of capsules or similar small containers for oral use
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0092—Hollow drug-filled fibres, tubes of the core-shell type, coated fibres, coated rods, microtubules or nanotubes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nanotechnology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PH35541A 1986-07-15 1987-07-15 Controlled release drug-containing fibers PH24299A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US88597586A 1986-07-15 1986-07-15

Publications (1)

Publication Number Publication Date
PH24299A true PH24299A (en) 1990-05-29

Family

ID=25388112

Family Applications (1)

Application Number Title Priority Date Filing Date
PH35541A PH24299A (en) 1986-07-15 1987-07-15 Controlled release drug-containing fibers

Country Status (18)

Country Link
EP (1) EP0253554A3 (ko)
JP (1) JPS6323815A (ko)
KR (1) KR900000512B1 (ko)
CN (1) CN87104918A (ko)
AU (1) AU574955B2 (ko)
CA (1) CA1296632C (ko)
DD (1) DD266027A5 (ko)
DK (1) DK364987A (ko)
FI (1) FI873114A (ko)
HU (1) HUT45195A (ko)
IL (1) IL83136A0 (ko)
NO (1) NO872924L (ko)
NZ (1) NZ221071A (ko)
PH (1) PH24299A (ko)
PL (1) PL266839A1 (ko)
PT (1) PT85315B (ko)
YU (1) YU46903B (ko)
ZA (1) ZA875125B (ko)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4837111A (en) * 1988-03-21 1989-06-06 Alza Corporation Dosage form for dispensing drug for human therapy
US5198251A (en) * 1989-04-19 1993-03-30 Wm. Wrigley Jr. Company Gradual release structures for chewing gum
US5108762A (en) * 1989-04-19 1992-04-28 Wm. Wrigley Jr. Company Gradual release structures for chewing gum
US5229148A (en) * 1989-04-19 1993-07-20 Wm. Wrigley Jr. Company Method of combining active ingredients with polyvinyl acetates
US5154939A (en) * 1989-04-19 1992-10-13 Wm. Wrigley Jr. Company Use of salt to improve extrusion encapsulation of chewing gum ingredients
AU639645B2 (en) * 1989-10-10 1993-07-29 Wm. Wrigley Jr. Company Gradual release structures made from fiber spinning techniques
AU7991191A (en) * 1990-05-23 1991-12-10 Southwest Research Institute Filament system for delivering a medicament and method
NZ245076A (en) * 1992-10-07 1994-09-27 William Leslie Porter Animal feed supplement comprising an at least partly oxidised alloy of copper in combination with at least one other trace element
US5538735A (en) * 1993-02-19 1996-07-23 Ahn; Sam S. Method of making a drug delivery system using hollow fibers
EP0849265A1 (de) * 1996-12-20 1998-06-24 HEUMANN PHARMA GmbH Neue polymorphe Form von Doxazosin-Mesylat (Form II)
PL204627B1 (pl) 1999-02-22 2010-01-29 Bayer Innovation Gmbh Sposób regulowania stopnia biologicznej degradacji przędzonego z zolu krzemionkowego włókna krzemionkowego, włókno krzemionkowe i jego zastosowanie
US6488962B1 (en) * 2000-06-20 2002-12-03 Depomed, Inc. Tablet shapes to enhance gastric retention of swellable controlled-release oral dosage forms
US20040249364A1 (en) * 2003-06-03 2004-12-09 Ilya Kaploun Device and method for dispensing medication to tissue lining a body cavity
US20050002996A1 (en) * 2003-07-02 2005-01-06 Milan Sojka Sustained release compositions and controlled delivery method
US20150139913A1 (en) * 2012-06-04 2015-05-21 Migrata U.K. Limited Medical use of particles of titanium and/or titanium oxide
AU2015274456B2 (en) * 2014-06-11 2020-03-26 Massachusetts Institute Of Technology Self-assembled residence devices and related methods
CA3002916A1 (en) 2015-10-23 2017-04-27 Lyndra, Inc. Gastric residence systems for sustained release of therapeutic agents and methods of use thereof
WO2017075096A1 (en) * 2015-10-26 2017-05-04 Blaesi Aron H Solid dosage form immediate drug release and apparatus and method for manufacture thereof
SG11201804384UA (en) 2015-12-08 2018-06-28 Lyndra Inc Geometric configurations for gastric residence systems
AU2017336154B2 (en) 2016-09-30 2023-11-09 Lyndra Therapeutics, Inc. Gastric residence systems for sustained delivery of adamantane-class drugs
JP2023553202A (ja) 2020-12-08 2023-12-20 ルミナント バイオテク コーポレーション リミテッド 動物に物質を送達するための装置および方法の改善

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL8401912A (nl) * 1984-06-15 1986-01-02 Tno Met aktieve stof beladen biodegradeerbare polymeersubstraten, geschikt voor het gecontroleerd afgeven van de aktieve stof door middel van een membraan.
US4673565A (en) * 1985-05-03 1987-06-16 E. I. Du Pont De Nemours And Company Pharmaceutical compositions containing hollow fine tubular drug delivery systems

Also Published As

Publication number Publication date
YU46903B (sh) 1994-06-24
AU574955B2 (en) 1988-07-14
FI873114A0 (fi) 1987-07-14
DK364987D0 (da) 1987-07-14
NO872924L (no) 1988-01-18
KR880001280A (ko) 1988-04-22
NZ221071A (en) 1990-03-27
ZA875125B (en) 1988-03-30
YU130287A (en) 1988-10-31
PT85315B (pt) 1990-04-30
IL83136A0 (en) 1987-12-31
DD266027A5 (de) 1989-03-22
PL266839A1 (en) 1988-07-21
FI873114A (fi) 1988-01-16
AU7562687A (en) 1988-01-21
EP0253554A3 (en) 1988-07-20
JPS6323815A (ja) 1988-02-01
HUT45195A (en) 1988-06-28
KR900000512B1 (ko) 1990-01-31
CN87104918A (zh) 1988-01-27
CA1296632C (en) 1992-03-03
DK364987A (da) 1988-01-16
PT85315A (en) 1987-08-01
EP0253554A2 (en) 1988-01-20
NO872924D0 (no) 1987-07-14

Similar Documents

Publication Publication Date Title
GB2207353B (en) Controlled release formulation
EP0306236A3 (en) Controlled release formulations
EP0251459A3 (en) Controlled release pharmaceutical composition
ZA875125B (en) Controlled release drug-containing fibers
IL82806A0 (en) Sustained release capsule
EP0320882A3 (en) Demultiplexer system
GB2218905B (en) Controlled release pharmaceutical
GB8510639D0 (en) Drug release device
GB8721040D0 (en) Respirators
ZA892099B (en) Fibres
JPS6490279A (en) Silicone release
GB8719093D0 (en) Fibre preparation
EP0254274A3 (en) Release agent
GB8628436D0 (en) Structural member
GB8607072D0 (en) Retaining means
EP0313338A3 (en) Optically active-2-biphenylpyridines
AU7050587A (en) Intra-ruminal controlled release device
EP0378691A4 (en) Laser-guide fiber
IE871898L (en) Controlled release drug containing fibres.
GB8708872D0 (en) Retaining means
ZA853109B (en) Drug release device
IE863030L (en) Controlled release composition
IE862306L (en) Controlled release tablet
BG43160A1 (en) Controlled optic system
ZA896012B (en) Controlled release formulations